![]() |
Volumn 3, Issue 5, 2005, Pages 1092-1093
|
The poor quality of streptokinase products in use in developing countries [4]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHROMOGENIC SUBSTRATE;
FIBRIN;
FIBRINOLYTIC AGENT;
STREPTOKINASE;
DRUG;
PLASMINOGEN;
PLASMINOGEN ACTIVATOR;
ACUTE DISEASE;
DEVELOPING COUNTRY;
DRUG EFFICACY;
HEART INFARCTION;
HUMAN;
IMMUNOGENICITY;
LETTER;
MEDICAL LITERATURE;
PLASMINOGEN ACTIVATION;
POLYACRYLAMIDE GEL ELECTROPHORESIS;
PRIORITY JOURNAL;
QUALITY CONTROL;
STANDARDIZATION;
WORLD HEALTH ORGANIZATION;
ARTICLE;
CHEMISTRY;
DRUG INDUSTRY;
HEALTH CARE QUALITY;
SAFETY;
STANDARD;
CONSUMER PRODUCT SAFETY;
DEVELOPING COUNTRIES;
DRUG INDUSTRY;
ELECTROPHORESIS, POLYACRYLAMIDE GEL;
FIBRIN;
FIBRINOLYTIC AGENTS;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
PLASMINOGEN;
PLASMINOGEN ACTIVATORS;
QUALITY ASSURANCE, HEALTH CARE;
QUALITY CONTROL;
STREPTOKINASE;
|
EID: 23844490877
PISSN: 15387933
EISSN: 15387836
Source Type: Journal
DOI: 10.1111/j.1538-7836.2005.01271.x Document Type: Letter |
Times cited : (11)
|
References (6)
|